Literature DB >> 24766756

Predictors of pretreatment commitment to abstinence: results from the COMBINE study.

Kelly S DeMartini1, Eric G Devine2, Carlo C DiClemente3, Daniel J Martin4, Lara A Ray5, Stephanie S O'Malley6.   

Abstract

OBJECTIVE: Patients entering treatment for alcohol problems do not have uniform treatment goals, and a pretreatment drinking goal has a significant impact on treatment outcome. The objective of this study was to understand better how an array of individual characteristics, including factors that affect treatment, are related to treatment goals before beginning alcohol treatment in the COMBINE (Combining Medications and Behavioral Interventions) Study.
METHOD: Participants were alcohol-dependent individuals (N = 1,156; 357 women) recruited at 11 outpatient academic alcoholism-treatment clinics across the United States to participate in a randomized, double-blind, placebo-controlled trial that combined behavioral intervention with acamprosate and/or naltrexone. Treatment goal was coded as controlled drinking, conditional abstinence, or total abstinence. Multinomial logistic regressions assessed whether there were significant relationships between predictor variables and pretreatment goal selection.
RESULTS: Lower levels of alcohol-related consequences, lower readiness to change, higher family income, more daily drinkers in social network, and lack of prior treatment or Alcoholics Anonymous engagement predicted choice of a controlled drinking goal over a total abstinence goal. Fewer alcohol-related consequences, lower readiness to change, and more daily drinkers in-network predicted choice of a conditional abstinence goal over a total abstinence goal.
CONCLUSIONS: Higher levels of functioning, lower levels of consequences, no prior involvement in treatment and Alcoholics Anonymous, and a more drinking-saturated social environment are associated with the choice of a non-abstinence goal.

Entities:  

Mesh:

Year:  2014        PMID: 24766756      PMCID: PMC4002857          DOI: 10.15288/jsad.2014.75.438

Source DB:  PubMed          Journal:  J Stud Alcohol Drugs        ISSN: 1937-1888            Impact factor:   2.582


  35 in total

Review 1.  Harm reduction approaches to alcohol use: health promotion, prevention, and treatment.

Authors:  G Alan Marlatt; Katie Witkiewitz
Journal:  Addict Behav       Date:  2002 Nov-Dec       Impact factor: 3.913

2.  Characteristics of volunteers for a controlled drinking training program.

Authors:  D S Cannon; T B Baker; N O Ward
Journal:  J Stud Alcohol       Date:  1977-09

3.  Goal choice of alcoholics: a comparison of those who choose total abstinence vs. those who choose responsible, controlled drinking.

Authors:  J S Pachman; D W Foy; M Van Erd
Journal:  J Clin Psychol       Date:  1978-07

4.  Alcohol dependence syndrome: measurement and validation.

Authors:  H A Skinner; B A Allen
Journal:  J Abnorm Psychol       Date:  1982-06

5.  The natural history of alcoholism over four years after treatment.

Authors:  H M Pettinati; A A Sugerman; N DiDonato; H S Maurer
Journal:  J Stud Alcohol       Date:  1982-03

6.  Decomposing the relationships between pretreatment social network characteristics and alcohol treatment outcome.

Authors:  William H Zywiak; Richard Longabaugh; Philip W Wirtz
Journal:  J Stud Alcohol       Date:  2002-01

7.  Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study.

Authors: 
Journal:  Alcohol Clin Exp Res       Date:  2003-07       Impact factor: 3.455

8.  Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods.

Authors: 
Journal:  Alcohol Clin Exp Res       Date:  2003-07       Impact factor: 3.455

9.  An investigation of coronary heart disease in families. The Framingham offspring study.

Authors:  W B Kannel; M Feinleib; P M McNamara; R J Garrison; W P Castelli
Journal:  Am J Epidemiol       Date:  1979-09       Impact factor: 4.897

10.  Acceptance of non-abstinence goals by addiction professionals in the United States.

Authors:  Alan K Davis; Harold Rosenberg
Journal:  Psychol Addict Behav       Date:  2012-10-22
View more
  20 in total

Review 1.  Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.

Authors:  Megan M Yardley; Lara A Ray
Journal:  Addict Biol       Date:  2016-02-01       Impact factor: 4.280

2.  Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder.

Authors:  Katie Witkiewitz; Henry R Kranzler; Kevin A Hallgren; Stephanie S O'Malley; Daniel E Falk; Raye Z Litten; Deborah S Hasin; Karl F Mann; Raymond F Anton
Journal:  Alcohol Clin Exp Res       Date:  2018-11-05       Impact factor: 3.455

3.  Reduction in non-abstinent World Health Organization (WHO) drinking risk levels and drug use disorders: 3-year follow-up results in the US general population.

Authors:  Justin Knox; Melanie Wall; Katie Witkiewitz; Henry R Kranzler; Daniel E Falk; Raye Litten; Karl Mann; Stephanie S O'Malley; Jennifer Scodes; Raymond Anton; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2019-05-29       Impact factor: 4.492

4.  Drink goal difficulty effect on outcomes in moderation-based alcohol treatment for sexual minority men.

Authors:  Svetlana Levak; Alexis N Kuerbis; Jon Morgenstern
Journal:  J Subst Abuse Treat       Date:  2020-01-09

5.  Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking.

Authors:  Donald M Dougherty; Tara E Karns; Jillian Mullen; Yuanyuan Liang; Sarah L Lake; John D Roache; Nathalie Hill-Kapturczak
Journal:  Drug Alcohol Depend       Date:  2014-12-31       Impact factor: 4.492

6.  Reduction in non-abstinent WHO drinking risk levels and depression/anxiety disorders: 3-year follow-up results in the US general population.

Authors:  Justin Knox; Jennifer Scodes; Melanie Wall; Katie Witkiewitz; Henry R Kranzler; Daniel Falk; Raye Litten; Karl Mann; Stephanie S O'Malley; Raymond Anton; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2019-02-14       Impact factor: 4.492

Review 7.  Prevention, screening, and treatment for heavy drinking and alcohol use disorder.

Authors:  Justin Knox; Deborah S Hasin; Farren R R Larson; Henry R Kranzler
Journal:  Lancet Psychiatry       Date:  2019-10-17       Impact factor: 27.083

8.  Recovery Goals and Long-term Treatment Preference in Persons Who Engage in Nonmedical Opioid Use.

Authors:  Kaitlyn R Hay; Andrew S Huhn; David Andrew Tompkins; Kelly E Dunn
Journal:  J Addict Med       Date:  2019 Jul/Aug       Impact factor: 3.702

9.  World Health Organization risk drinking level reductions are associated with improved functioning and are sustained among patients with mild, moderate and severe alcohol dependence in clinical trials in the United States and United Kingdom.

Authors:  Katie Witkiewitz; Nick Heather; Daniel E Falk; Raye Z Litten; Deborah S Hasin; Henry R Kranzler; Karl F Mann; Stephanie S O'Malley; Raymond F Anton
Journal:  Addiction       Date:  2020-03-10       Impact factor: 6.526

10.  Reduction of ethanol intake by corticotropin-releasing factor receptor-1 antagonist in "heavy-drinking" mice in a free-choice paradigm.

Authors:  Diego Correia; Bruno Jacson Martynhak; Marcela Pereira; Isadora Pozzetti Siba; Andrea Frozino Ribeiro; Rosana Camarini; Roseli Boerngen-Lacerda
Journal:  Psychopharmacology (Berl)       Date:  2015-03-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.